Total Compensation Measurement. Global TCM Participants. Turkey

Size: px
Start display at page:

Download "Total Compensation Measurement. Global TCM Participants. Turkey"

Transcription

1 Total Compensation Measurement 2008 Global TCM Participants Turkey

2 Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for Measure Sales (Fiscal year 2007in YTL) Average Median Number of White Collars Average 270 Median 89 Number of Blue Collars Average 771 Median 203 Number of Employees Average 800 Median 247 Hewitt Associates 1 Turkey 2008 Hewitt Global TCM Participants

3 Ownership Ownership US Multinational 31% 21 European Multinational 66% 44 Asian Multinational 3% 4 US Multinational 31% Ownership Asian Multinational 3% European Multinational 66% Hewitt Associates 2 Turkey 2008 Hewitt Global TCM Participants

4 Industry Industry Representation Aerospace 1 Automotive/Vehicle Manufacturing 16.4% 11 Building Materials 3.0% 2 Chemicals 1 Consumer Products (durable) 4.5% 3 Consumer Products (non durable) 1 Engineering/Construction 1 Food/Beverage/Tobacco 6.0% 4 Hi-Tech 1 Hospitality/Restaurants 1 Medical Devices/Products 3.0% 2 Multi-Industry 1 Other Manufacturing 7.5% 5 Other Service 3.0% 2 Pharmaceutical 26.9% 18 Retail (Includes Wholesale and Distribution) 11.9% 8 Textiles/Apparel Manufacturing 1 Transport, Logistics 6.0% 4 Industry Textiles/Apparel Manufacturing Pharmaceutical 26.9% Other Service 3.0% Retail (Includes Wholesale and Distribution) 11.9% Transport, Logistics 6.0% Multi-Industry Aerospace Other Manufacturing 7.5% Automotive/Vehicle Building Materials Manufacturing 3.0% 16.4% Chemicals Consumer Products (durable) 4.5% Consumer Products (non durable) Food/Beverage/Tobacco 6.0% Hi-Tech Hospitality/Restaurants Engineering/Construction Medical Devices/Products 3.0% Hewitt Associates 3 Turkey 2008 Hewitt Global TCM Participants

5 Turkey 2008 TCM Participants - Alphabetical Order 3M Abbott Adil Işık Agility Logistics Air France AkçanSA Armada Hotel Astra Zeneca Autoliv Bak Ambalaj Bareks Baylas (Citroen) Baytur (Subaru) Boehringer Ingelheim Bosch Siemens Boston Scientific Bristol-Myers Squibb Brown-Forman C&A Cargill CarrefourSA Ceva Logistics Coca-Cola DHL Worldwide Express Docomo intertouch Edwards Lifesciences Eli Lilly and Company Emerson Process Management F Hoffmann-La Roche Ferroli Genzyme General Motors GlaxoSmithKline Gravure International Hal Optik Hal Optik Imperial Tobacco İnci Akü Intendis John Deere Johnson & Johnson Kimberly-Clark Laverda Mahle Mopisan MAN Mercedes-Benz Merck & Co Merck Serono Nalco Nike Novartis Pharma Omsan Logistics Özmaya Peugeot Pfizer Polibak Sandoz Schering-Plough Set Group Shaya Sodexho Teb Arval TeknoSA Tema Magazacilik (LC Waikiki) UCB Valeo Wyeth YKM Hewitt Associates 4 Turkey 2008 Hewitt Global TCM Participants

6 Turkey 2008 TCM Participants - by Industry Aerospace Air France Automotive/Vehicle Manufacturing Autoliv Baylas (Citroen) Baytur (Subaru) General Motors John Deere Laverda Mahle Mopisan MAN Mercedes-Benz Peugeot Valeo Building Materials AkçanSA Set Group Chemicals Nalco Consumer Products (durable) Bosch Siemens Brown-Forman Ferroli Consumer Products (nondurable) Kimberly-Clark Engineering/Construction Emerson Process Management Food/Beverage/Tobacco Cargill Coca-Cola Imperial Tobacco Özmaya Hi-Tech Docomo intertouch Hewitt Associates 5 Turkey 2008 Hewitt Global TCM Participants

7 Hospitality/Restaurants Armada Hotel Medical Devices/Products Boston Scientific Edwards Lifesciences Multi-Industry 3M Other Manufacturing Bak Ambalaj Bareks Gravure International İnci Akü Polibak Other Service Sodexho Teb Arval Pharmaceutical Abbott Astra Zeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly and Company F Hoffmann-La Roche Genzyme GlaxoSmithKline Intendis Johnson & Johnson Merck & Co Merck Serono Novartis Pharma Pfizer Sandoz Schering-Plough UCB Wyeth Retail (Includes Wholesale & Distribution) Adil Işık C&A CarrefourSA Hal Optik Shaya TeknoSA Tema Magazacilik (LC Waikiki) YKM Transportation services Nike Hewitt Associates 6 Turkey 2008 Hewitt Global TCM Participants

8 Transport, Logistics Agility Logistics Ceva Logistics DHL Worldwide Express Omsan Logistics Hewitt Associates 7 Turkey 2008 Hewitt Global TCM Participants

Trends in the pharmaceutical industry and potential impact on future innovation and access to medicines

Trends in the pharmaceutical industry and potential impact on future innovation and access to medicines Trends in the pharmaceutical industry and potential impact on future innovation and access to medicines The R&D Process: Long, Complex, and Costly Average cost of R&D is $1.2 Billion The Current Challenge

More information

Global R&D spending survey 2002-2004

Global R&D spending survey 2002-2004 Global R&D spending survey 2002-2004 Cientifica has surveyed the top 100 global corporate spenders in research and development over the last three years. Data was obtained from annual reports and encompasses

More information

Organizational Capital, R&D Assets, and Outsourcing

Organizational Capital, R&D Assets, and Outsourcing Organizational Capital, R&D Assets, and Outsourcing Wendy Li 2013 Federal Committee on Statistical Methodology Research Conference Bureau of Economic Analysis November 5, 2013 Motivation and Challenge

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage

More information

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for

More information

Fertilizing Compliance Professionals: Continuing Education. University of Miami October 24 26, 2012

Fertilizing Compliance Professionals: Continuing Education. University of Miami October 24 26, 2012 Fertilizing Compliance Professionals: Continuing Education University of Miami October 24 26, 2012 Why Choose UM? A Global Leader in Business Education and Research Established Expertise in Executive Education

More information

Serialization Technology - Seidenader: Integral Solution Provider

Serialization Technology - Seidenader: Integral Solution Provider Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your

More information

CHAPTER FOUR: CLINICAL TRIAL COST AND FUNDING... 30

CHAPTER FOUR: CLINICAL TRIAL COST AND FUNDING... 30 CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 INTENDED AUDIENCE... 2 METHODOLOGY... 2 ANALYST CREDENTIALS... 2 SCOPE OF REPORT... 2 INFORMATION SOURCES...

More information

The Hong Kong Association of The Pharmaceutical Industry

The Hong Kong Association of The Pharmaceutical Industry The Hong Kong Association of The Pharmaceutical Industry UNIT A, 20/F., TIMES MEDIA CENTRE, FAX: (852) 2865 6283 WEBSITE: www. hkapi.hk Position Paper on the Pharmacy and Poisons (Amendment) Bill 2014

More information

Europe Pradaxa Market Report 2016

Europe Pradaxa Market Report 2016 Report Information More information from: https://www.wiseguyreports.com/reports/650908 Europe Pradaxa Market Report 2016 Report / Search Code: WGR650908 Publish Date: 22 September, 2016 Price 1-user PDF

More information

ehealthinsight Series: Online Patient Recruitment Strategies

ehealthinsight Series: Online Patient Recruitment Strategies A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

As featured in. Orphan disease specialists find home with Big Pharma.

As featured in. Orphan disease specialists find home with Big Pharma. Orphan disease specialists find home with Big Pharma. By Maura Musciacco Senior Analyst January 2013 Tumbling over the patent cliff, many big pharma companies are being forced to find new strategies for

More information

Tuas Biomedical Park

Tuas Biomedical Park Tuas Biomedical Park About Tuas Biomedical Park Tuas Biomedical Park symbolises JTC s commitment in developing a world-class manufacturing hub for the biomedical industry. The park is located in Tuas View,

More information

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:

More information

- The need for sales force effectiveness for pharmaceutical companies and the factors that affect it.

- The need for sales force effectiveness for pharmaceutical companies and the factors that affect it. Brochure More information from http://www.researchandmarkets.com/reports/2204703/ Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and

More information

TABLE 2 RECOGNIZED AND POTENTIAL AUTOIMMUNE DISEASES AND THE SYSTEMS THEY EFFECT,

TABLE 2 RECOGNIZED AND POTENTIAL AUTOIMMUNE DISEASES AND THE SYSTEMS THEY EFFECT, CHAPTER ONE: INTRODUCTION... 1 REASONS FOR DOING THE STUDY... 1 STUDY GOALS AND OBJECTIVES... 1 SCOPE OF REPORT... 2 INTENDED AUDIENCE... 2 METHODOLOGIES AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS...

More information

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This

More information

2012 Corporate Social Responsibility and Sustainability Conference

2012 Corporate Social Responsibility and Sustainability Conference 2012 Corporate Social Responsibility and Sustainability Conference November 29, 2012 United Way Worldwide Network Mission: To improve lives by mobilizing the caring power of communities around the world

More information

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors

More information

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com

More information

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials

More information

EU Clinical Trials Register

EU Clinical Trials Register EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 euclinicaltrials@abbott.com

More information

2015 Employment Report

2015 Employment Report Corporate Connections. Career Results. 2015 Employment Report www.smeal.psu.edu/mba Corporate Connections. Career Results. 1 Table of Contents Class of 2015 Full-Time Employment Class of 2016 Internship

More information

Main Conference Agenda

Main Conference Agenda Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental

More information

Pharmaceutical Market Overview

Pharmaceutical Market Overview Strategy Operations Legal and Tax Pharmaceutical Market Overview Yerevan, 2014 2 So far, we have accomplished analytical reports in various fields, such as tourism development agriculture labor and social

More information

Buying Process and Negociation. from a Group of Pharmacies Point of View

Buying Process and Negociation. from a Group of Pharmacies Point of View Buying Process and Negociation from a Group of Pharmacies Point of View Agenda: Demographics Sector Analysis Trends Pharmaceutical Market Overview Pharmaceutical Retails Market Overview The Future Business

More information

KEY FACTS ON CORPORATE FOUNDATIONS

KEY FACTS ON CORPORATE FOUNDATIONS April 2011 KEY FACTS ON CORPORATE FOUNDATIONS Outlook for Corporate Foundation Giving Giving by the nation s approximately 2,700 grantmaking corporate foundations remained basically unchanged in 2010 at

More information

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for

More information

Medical Writing Takes Off in India

Medical Writing Takes Off in India Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com

More information

The World's Top 100 Pharmaceutical Companies

The World's Top 100 Pharmaceutical Companies Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,

More information

Pharmaceutical Marketing Disclosures

Pharmaceutical Marketing Disclosures Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,

More information

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Commercial Insight Osteoarthritis and Rheumatoid Arthritis A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and

More information

Sales Force Effectiveness in Pharmaceuticals

Sales Force Effectiveness in Pharmaceuticals Sales Force Effectiveness in Pharmaceuticals Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency GBI Research Report

More information

CAN-SPAM Act Rulemaking, Project No. R411008

CAN-SPAM Act Rulemaking, Project No. R411008 1301 K Street NW Suite 900 East Tower Washington DC 20005-3317 Telephone 202 230 5619 Facsimile 202 230 5300 June 27, 2005 By Hand Federal Trade Commission Office of the Secretary, Room H-159 600 Pennsylvania

More information

Pharma working capital performance highly variable

Pharma working capital performance highly variable April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the

More information

In the largest and perhaps the most ambitious collaborative

In the largest and perhaps the most ambitious collaborative FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section

More information

The United States False Claims Act Qui Tam Whistleblower Law

The United States False Claims Act Qui Tam Whistleblower Law The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com

More information

Analysis of Manufacturing Costs in Pharmaceutical Companies

Analysis of Manufacturing Costs in Pharmaceutical Companies J Pharm Innov (2008) 3:30 40 DOI 10.1007/s12247-008-9024-4 PERSPECTIVE Analysis of Manufacturing Costs in Pharmaceutical Companies Prabir Basu & Girish Joglekar & Saket Rai & Pradeep Suresh & John Vernon

More information

KEEPING CLINICAL TRIALS IN AUSTRALIA

KEEPING CLINICAL TRIALS IN AUSTRALIA OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought

More information

Pharmaceutical industry

Pharmaceutical industry 8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and

More information

La ricerca clinica farmacologica nel paziente anziano: un costo inutile o un dato assente?

La ricerca clinica farmacologica nel paziente anziano: un costo inutile o un dato assente? La ricerca clinica farmacologica nel paziente anziano: un costo inutile o un dato assente? 57 Congresso Nazionale SIGG Società Italiana di Gerontologia e Geriatria Dr. Marco Scatigna Direttore Medico e

More information

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a

More information

Manufacturer of drug substance

Manufacturer of drug substance Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin

More information

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and

More information

The Gold Standard for Processing and Packaging

The Gold Standard for Processing and Packaging PACK EXPO Las Vegas Exhibitor Prospectus The Gold Standard for Processing and Packaging 2 O YEARS co-located with: packexpolasvegas.com/exhibit2015 A Reliable Source of Excellence When you exhibit at PACK

More information

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries

More information

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association

More information

INVESTMENT CHOICES. Dr. Suzanne B. Badenhop Professor/Extension Specialist

INVESTMENT CHOICES. Dr. Suzanne B. Badenhop Professor/Extension Specialist INVESTMENT CHOICES Dr. Suzanne B. Badenhop Professor/Extension Specialist INVESTING 101 What is your investment objective? What is your age? What is your time horizon What is your risk comfort level? What

More information

Medical Professionalism in Lebanon: Challenges and Aspirations. Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut

Medical Professionalism in Lebanon: Challenges and Aspirations. Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut Medical Professionalism in Lebanon: Challenges and Aspirations Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut Medical Professionalism in Lebanon: Challenges and Aspirations

More information

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Stakeholder Insight: Insulin Use in Type 2 Diabetes A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes

More information

Toulouse University, Hôpital Larrey, Toulouse, France

Toulouse University, Hôpital Larrey, Toulouse, France 2177 Long-term Safety and Tolerability of Apremilast in Patients With Psoriasis: Analysis of Two Phase 3, Randomized, Controlled Trials (ESTEEM 1 and 2) Kristian Reich, MD 1 ; Kim Papp, MD 2 ; Kenneth

More information

Acknowledgements. Legal Notice

Acknowledgements. Legal Notice 1 Acknowledgements The 2011 EU Industrial R&D Investment Scoreboard (Draft) has been published within the context of the Industrial Research Monitoring and Analysis (IRMA) activities that are jointly carried

More information

ACCT 738 / FINA 756 FINANCIAL STATEMENT ANALYSIS SRING 2008

ACCT 738 / FINA 756 FINANCIAL STATEMENT ANALYSIS SRING 2008 1 ACCT 738 / FINA 756 FINANCIAL STATEMENT ANALYSIS SRING 2008 INSTRUCTOR: Timothy S. Doupnik CLASS: TTH 2:00-3:15, BA 350 OFFICE: BA 310 HOURS: TTH 1:00 2:00, drop-in, and by appointment TELEPHONE: 777-7450

More information

INCENTIVE COMPENSATION CONFERENCE

INCENTIVE COMPENSATION CONFERENCE Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

Pharma working capital leaves room for improvement

Pharma working capital leaves room for improvement October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.

More information

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017

More information

Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch

Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch Pharmaceutical Products Liability Michael C. Dubin Stephen Knobloch Objectives Objective 1 Get Actuaries Thinking About Adding Value to New Areas Objective 2 Provide example using pharmaceutical industry

More information

Rx-360 An International Pharmaceutical Supply Chain Consortium

Rx-360 An International Pharmaceutical Supply Chain Consortium Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)

More information

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit 2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China

More information

Global Pharmaceuticals Marketing Channel Reference EDITION

Global Pharmaceuticals Marketing Channel Reference EDITION Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry

More information

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product

More information

Baxalta 2015 Investor Conference May 19, 2015

Baxalta 2015 Investor Conference May 19, 2015 Eric W. Foster is expected to serve as Senior Vice President and Chief Information Officer for Baxalta upon completion of the separation. Mr. Foster brings more than 15 years of IT leadership experience

More information

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: crtraining@avesthagen.com PG Diploma In Clinical Research,

More information

Company Overview June 2011

Company Overview June 2011 June 2011 Pop Design is the Architectural and Interior Design Company which was founded in 1992 by Architect Murat Fatih Mısırlı in İstanbul. More than 10.000 m 2 of corporate interior design & production

More information

Global Antibacterial Drugs Market

Global Antibacterial Drugs Market Brochure More information from http://www.researchandmarkets.com/reports/3498706/ Global Antibacterial Drugs Market 2015-2019 Description: About antibacterial drugs Antibacterial drugs are chemical compounds

More information

Global Top 100 Companies by market capitalisation

Global Top 100 Companies by market capitalisation www.pwc.com/top100 Companies by market capitalisation 31 March 2016 update An IPO Centre publication Contents Section 1 Highlights and trends 3 Section 2 Year-on-year comparison: 2016 vs. 2015 12 Section

More information

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation

More information

Malignant Mesothelioma - Pipeline Review, H1 2015

Malignant Mesothelioma - Pipeline Review, H1 2015 Brochure More information from http://www.researchandmarkets.com/reports/3308784/ Malignant Mesothelioma - Pipeline Review, H1 2015 Description: Malignant Mesothelioma - Pipeline Review, H1 2015 Summary

More information

Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions

Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Philip S. Brewster Brewster Law Firm LLC July 29, 2014 Schering Charitable

More information

The RECMA range of global tools in 2011

The RECMA range of global tools in 2011 13 Global Evaluation reports and databases in The RECMA range of global tools in This brochure presents the list of the Global evaluation reports and databases to be d in. It does not include the Domestic

More information

Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer

Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists

More information

Metastatic Breast Cancer - Pipeline Review, Q1 2011

Metastatic Breast Cancer - Pipeline Review, Q1 2011 Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary

More information

Discussion paper on global harmonization of the traceability system for drugs with globally harmonised barcodes

Discussion paper on global harmonization of the traceability system for drugs with globally harmonised barcodes Purpose The purpose of this paper is to facilitate the discussions for a transition toward a globally harmonised barcoding system for pharmaceuticals in China, using GS1 global standards and building on

More information

Annual Press Conference 2012. Business Year 2011

Annual Press Conference 2012. Business Year 2011 Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation

More information

Shark Attack: Pharmaceutical Industry s Feeding Frenzy

Shark Attack: Pharmaceutical Industry s Feeding Frenzy Shark Attack: Pharmaceutical Industry s Feeding Frenzy Ver. 1.1 October 24, 2016 Prepared by the Institute for Health and Socio-Economic Policy The Institute for Health & Socio-Economic Policy (IHSP) is

More information

The Importance of the Pharmaceutical Industry for Switzerland

The Importance of the Pharmaceutical Industry for Switzerland Study on behalf of Interpharma The Importance of the Pharmaceutical Industry for Switzerland BAK Basel Economics Michael Grass, Samuel Mösle In collaboration with Polynomics Published by: Interpharma,

More information

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine

More information

Manufacturer of drug substance

Manufacturer of drug substance Original s and Biosimilars (marketing authorizations in the EU) Date: December 2016 1) Somatropin s ORIGINAL PRODUCTS: Marketing Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli

More information

Example of High Dimensional Contract

Example of High Dimensional Contract Example of High Dimensional Contract An exotic high dimensional option is the ING-Coconote option (Conditional Coupon Note), whose lifetime is 8 years (24-212). The interest rate paid is flexible. In the

More information

EUROPE S TOP GROWTH DOMESTIC PRODUCT

EUROPE S TOP GROWTH DOMESTIC PRODUCT Paris La Défense business district Stevanzz / Fotolia Europe s leading economic region EUROPE S TOP GROWTH DOMESTIC PRODUCT The Paris Region's GDP is equivalent to that of the Netherlands, and higher than

More information

Digital Leaders Deal With a Range of Organizational Challenges

Digital Leaders Deal With a Range of Organizational Challenges May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij

More information

A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry

A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry Executive Summary The life sciences industry is under pressure from the decline in the discovery of block-buster

More information

Commercial Perspectives: Multiple Sclerosis

Commercial Perspectives: Multiple Sclerosis A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading

More information

The Cost of Innovation in the Pharmaceutical Industry A Review

The Cost of Innovation in the Pharmaceutical Industry A Review The Cost of Innovation in the Pharmaceutical Industry A Review Prof. Dr. Alexander Schuhmacher, Reutlingen University, March 2014 Conflict of interest: nothing to disclose 1 Executive Summary Despite scientific,

More information

Outline of the case study analysis. Summary of analysis results

Outline of the case study analysis. Summary of analysis results Outline of the case study analysis In order to examine how IAS 38 Intangible assets is applied in practice by EU corporations, we surveyed the accounting treatment of internally generated development costs

More information

Designing two Greenfield site Universities for the 21 st Century

Designing two Greenfield site Universities for the 21 st Century Designing two Greenfield site Universities for the 21 st Century Prof. Oğuz Babüroğlu Sabancı University and ARAMA Consulting İstanbul, Turkey Some Major Changes Interdependent and interconnected world

More information

Bio business in Asia FICTION OR FACT? Development of successful indigenous biotechnology industries in Asia. Regional focus

Bio business in Asia FICTION OR FACT? Development of successful indigenous biotechnology industries in Asia. Regional focus Bio business in Asia FICTION OR FACT? Development of successful indigenous biotechnology industries in Asia By Dr Guy Heathers Singapore, South Korea and Taiwan three countries that have made the development

More information

Biopharmaceutical Raw Materials throughout the Product Lifecycle

Biopharmaceutical Raw Materials throughout the Product Lifecycle February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing

More information

Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability

Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses Organizational Dynamics Programs 5-4-2010 Problems Facing the Pharmaceutical Industry and Approaches to Ensure

More information

Pharma MNCs focus on branded generics in India to drive growth

Pharma MNCs focus on branded generics in India to drive growth s focus on branded generics in India to drive growth Contacts Anjan Ghosh aghosh@icraindia.com +91-22-30470006 Subrata Ray subrata@icraindia.com +91-22-30470027 Gaurav Jain gaurav.jain@icraindia.com +91-20-25560195

More information

Partial list of companies offering Volunteer Incentive Plans and/or Matching Gifts Programs

Partial list of companies offering Volunteer Incentive Plans and/or Matching Gifts Programs (Please check with your human resources department to verify if your company has a program. If they do and you do not see your company on this list please email us at admin@spartanband.com to add your

More information

100 BEST COMPANIES 2015

100 BEST COMPANIES 2015 30TH ANNIVERSARY 100 BEST COMPANIES 2015 EXECUTIVE SUMMARY BACKGROUND ON THE INITIATIVE For 30 years, the Working Mother 100 Best Companies have set the standard for work life practices in the United States.

More information

Careers in the Pharmaceutical and Biotechnology Industry: Job Classifications and Hiring Needs of the Top Nine Companies

Careers in the Pharmaceutical and Biotechnology Industry: Job Classifications and Hiring Needs of the Top Nine Companies Careers in the Pharmaceutical and Biotechnology Industry: Job Classifications and Hiring Needs of the Top Nine Companies, MBS Molly Schmid, Ph.D. Table of Contents Introduction.2 Methodology.. 2 Results

More information

Who We Are. The Challenge

Who We Are. The Challenge Who We Are Since 1966, The Consortium for Graduate Study in Management has worked to increase diversity in MBA programs and corporate America. The Consortium is an alliance of 18 top graduate MBA programs,

More information